Substance
TENOFOVIR ALAFENAMIDE FUMARATE
Global reference: every product and company linked to this substance.
- cas: 1392275-56-7
- ncit: C152559
- pubchem_cid: 71492247
- rxnorm: 1721604
- unii: FWF6Q91TZO
BIKTARVY COMPONENT TENOFOVIR ALAFENAMIDE FUMARATE · DESCOVY COMPONENT TENOFOVIR ALAFENAMIDE FUMARATE · GS-7340 HEMIFUMARATE · GS-7340-03 · ODEFSEY COMPONENT TENOFOVIR ALAFENAMIDE FUMARATE · SYMTUZA COMPONENT TENOFOVIR ALAFENAMIDE FUMARATE · TENOFOVIR ALAFENAMIDE FUMARATE [JAN] · TENOFOVIR ALAFENAMIDE FUMARATE [USAN] · Tenofovir alafenamide fumarate [WHO-DD] · VEMLIDY
Revenue by product (6)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| GILEAD SCIENCES INC. COMMON STOCK | BIKTARVY | Q2 2026 | $3.8B* |
| GILEAD SCIENCES INC. COMMON STOCK | DESCOVY | Q2 2026 | $967.0M* |
| JOHNSON & JOHNSON COMMON STOCK | SYMTUZA | Q2 2026 | $372.0M* |
| GILEAD SCIENCES INC. COMMON STOCK | GENVOYA | Q2 2026 | $289.0M* |
| GILEAD SCIENCES INC. COMMON STOCK | VEMLIDY | Q2 2026 | $289.0M |
| GILEAD SCIENCES INC. COMMON STOCK | ODEFSEY | Q2 2026 | $239.0M* |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (6)
- BIKTARVY · GILEAD SCIENCES INC. COMMON STOCK
- DESCOVY · GILEAD SCIENCES INC. COMMON STOCK
- GENVOYA · GILEAD SCIENCES INC. COMMON STOCK
- ODEFSEY · GILEAD SCIENCES INC. COMMON STOCK
- SYMTUZA · JOHNSON & JOHNSON COMMON STOCK
- VEMLIDY · GILEAD SCIENCES INC. COMMON STOCK